drugset / Trial / NCT02358473
Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety of mogamulizumab in combination with docetaxel in adult subjects with previously treated locally advanced or metastatic non-small cell lung cancer.
Timeline
- Start
- 2015-01
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mogamulizumab | Monoclonal antibody | — | Intravenous |
| Background | Docetaxel | Small molecule | — | Intravenous |